MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma.

Jinmin SunSicheng WuWenyu ZhaoSenrui XueLei ZhangJing Ren

Published in: Frontiers in oncology (2024)

Our findings provide evidence of the clinical relevance of MAPKAPK2 in prognosis evaluation of glioma patients and highlight the underlying significance of MAPKAPK2 in glioma therapy.

Keyphrases

poor prognosis
end stage renal disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
long non coding rna
stem cells
oxidative stress
protein kinase
signaling pathway
patient reported outcomes
pi k akt